Clinical Study of ATTR-CM — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Clinical Study of ATTR-CM — Stella

Recruiting

Back to Transthyroxine Amyloidosis Cardiomyopathy trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

China

xiaohong University PAN, Hangzhou, Zhejiang

Key details

Phase

Post-approval study

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Enrollment target

~100 participants

Started

June 2021

Primary completion

June 2031

Age range

18 Years – 80 Years

Last updated January 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov